These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 17634162

  • 1. The Amplatzer Membranous VSD Occluder and the vulnerability of the atrioventricular conduction system.
    Fischer G, Apostolopoulou SC, Rammos S, Schneider MB, Bjørnstad PG, Kramer HH.
    Cardiol Young; 2007 Oct; 17(5):499-504. PubMed ID: 17634162
    [Abstract] [Full Text] [Related]

  • 2. Transcatheter closure of congenital ventricular septal defect with Amplatzer septal occluders.
    Carminati M, Butera G, Chessa M, Drago M, Negura D, Piazza L.
    Am J Cardiol; 2005 Dec 19; 96(12A):52L-58L. PubMed ID: 16399093
    [Abstract] [Full Text] [Related]

  • 3. Complete heart block associated with device closure of perimembranous ventricular septal defects.
    Predescu D, Chaturvedi RR, Friedberg MK, Benson LN, Ozawa A, Lee KJ.
    J Thorac Cardiovasc Surg; 2008 Nov 19; 136(5):1223-8. PubMed ID: 19026807
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Percutaneous closure of perimembranous ventricular septal defects with Amplatzer occluders--a single centre experience.
    Szkutnik M, Kusa J, Białkowski J.
    Kardiol Pol; 2008 Sep 19; 66(9):941-7; discussion 948-9. PubMed ID: 18924021
    [Abstract] [Full Text] [Related]

  • 6. Transcatheter closure of congenital muscular ventricular septal defect.
    Arora R, Trehan V, Thakur AK, Mehta V, Sengupta PP, Nigam M.
    J Interv Cardiol; 2004 Apr 19; 17(2):109-15. PubMed ID: 15104774
    [Abstract] [Full Text] [Related]

  • 7. Invasive measurements of atrioventricular conduction parameters prior to and following ventricular septal defect closure with the amplatzer device.
    Kramoh EK, Dahdah N, Fournier A, Sanatani S, Hosking M, Miró J.
    J Invasive Cardiol; 2008 May 19; 20(5):212-6. PubMed ID: 18460702
    [Abstract] [Full Text] [Related]

  • 8. Percutaneous closure of perimembranous ventricular septal defects with the Amplatzer device: technical and morphological considerations.
    Pedra CA, Pedra SR, Esteves CA, Pontes SC, Braga SL, Arrieta SR, Santana MV, Fontes VF, Masura J.
    Catheter Cardiovasc Interv; 2004 Mar 19; 61(3):403-10. PubMed ID: 14988905
    [Abstract] [Full Text] [Related]

  • 9. Transcatheter closure of muscular ventricular septal defect using the Amplatzer devices.
    Djer MM, Latiff HA, Alwi M, Samion H, Kandavello G.
    Heart Lung Circ; 2006 Feb 19; 15(1):12-7. PubMed ID: 16473785
    [Abstract] [Full Text] [Related]

  • 10. Catheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: initial clinical experience.
    Hijazi ZM, Hakim F, Haweleh AA, Madani A, Tarawna W, Hiari A, Cao QL.
    Catheter Cardiovasc Interv; 2002 Aug 19; 56(4):508-15. PubMed ID: 12124963
    [Abstract] [Full Text] [Related]

  • 11. [Risk factors for arrhythmia early after transcatheter closure of perimembranous ventricular septal defects].
    Sun XJ, Gao W, Zhou AQ, Yu ZQ, Li F, Huang MR, Sun K.
    Zhonghua Er Ke Za Zhi; 2005 Oct 19; 43(10):767-71. PubMed ID: 16255857
    [Abstract] [Full Text] [Related]

  • 12. Evolution of transcatheter closure of perimembranous ventricular septal defects in a single centre.
    Kenny D, Morgan G, Bajwa A, Farrow C, Parry A, Caputo M, Tometzki A, Martin R.
    Catheter Cardiovasc Interv; 2009 Mar 01; 73(4):568-75. PubMed ID: 19235245
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Device closure of congenital ventricular septal defects with Amplatzer devices: first experiences in Turkey.
    Celiker A, Ozkutlu S, Karagöz T, Erdoğan I, Ozer S, Aypar E.
    Turk J Pediatr; 2008 Mar 01; 50(2):106-13. PubMed ID: 18664072
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transcatheter closure of perimembranous ventricular septal defects using amplatzer asymmetric ventricular septal defect occluder: preliminary experience with 18-month follow up.
    Pinto RJ, Dalvi BV, Sharma S.
    Catheter Cardiovasc Interv; 2006 Jul 01; 68(1):145-52. PubMed ID: 16763998
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Initial human experience with the Amplatzer perimembranous ventricular septal occluder device.
    Bass JL, Kalra GS, Arora R, Masura J, Gavora P, Thanopoulos BD, Torres W, Sievert H, Carminati M, Fischer G, Ewert P.
    Catheter Cardiovasc Interv; 2003 Feb 01; 58(2):238-45. PubMed ID: 12552550
    [Abstract] [Full Text] [Related]

  • 20. [Management of the arrhythmia around the procedure of transcatheter closure of ventricular septal defects in pediatric patients].
    Xie YM, Zhang ZW, Li YF, Qian MY, Wang HS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Dec 01; 33(12):1092-4. PubMed ID: 16563277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.